30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Integrated Biopharma Inc (INBP)

Track

The most recent insider transaction at Integrated Biopharma Inc. occurred on June 27, 2012, when the CEO and President sold 250,000 shares for $22,500. Prior to this, there were several buy and sell transactions by other insiders dating back to April 2009. The last reported earnings were on May 14, 2025.
Stock chart
Ticker: INBP Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
KAY E GERALD
CEO AND PRESIDENT
1 sale — total 22,500 USD
Sale 27 Jun 2012
Value US$1,478,120.52 | Price 447.09 | Shares 48,355
Buy 6 Apr 2009
Value US$3,159,407.62 | Price 308.45 | Shares 92,430
Buy 22 Mar 2005
Value US$32,200.00 | Price 6.44 | Shares 5,000
Sale 12 Jan 2005
Value US$4,155.00 | Price 6.93 | Shares 600
Sale 11 Jan 2005
Value US$6,210.00 | Price 6.90 | Shares 900
Sale 11 Jan 2005
Value US$6,900.00 | Price 6.90 | Shares 1,000
Sale 10 Jan 2005
Value US$3,500.00 | Price 7.00 | Shares 500
Sale 7 Jan 2005
Value US$20,550.00 | Price 6.85 | Shares 3,000
Sale 7 Jan 2005
Value US$3,500.00 | Price 7.00 | Shares 500
Sale 8 Jan 2004
Value US$28,160.00 | Price 12.80 | Shares 2,200
Sale 8 Jan 2004
Value US$6,435.00 | Price 12.87 | Shares 500
Sale 8 Jan 2004
Value US$3,870.00 | Price 12.90 | Shares 300
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2012-06-29 2012-06-27 S Sale KAY E GERALD

CEO AND PRESIDENT

Executive Director Large shareholder
48,355 -28.0%
447.09
US$1,478,121 		48,355 -28.0% 447.09 US$1,478,121
2009-10-28 2009-04-06 B Purchase DESANTIS CARL Non-Executive Director Large shareholder
92,430 +11.4%
308.45
US$3,159,408 		92,430 +11.4% 308.45 US$3,159,408
2005-03-24 2005-03-22 B Purchase KAY E GERALD

Chairman and CEO

Executive Director Large shareholder
14,953 -0.1%
323.84
US$3,195,063 		14,953 -0.1% 323.84 US$3,195,063
2005-01-14 2005-01-12 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
600 -1.0%
6.93
US$4,155 		600 -1.0% 6.93 US$4,155
2005-01-12 2005-01-11 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
900 -1.4%
6.90
US$6,210 		900 -1.4% 6.90 US$6,210
2005-01-12 2005-01-11 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
1,000 -1.5%
6.90
US$6,900 		1,000 -1.5% 6.90 US$6,900
2005-01-12 2005-01-10 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
500 -0.8%
7.00
US$3,500 		500 -0.8% 7.00 US$3,500
2005-01-11 2005-01-07 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
3,000 -4.2%
6.85
US$20,550 		3,000 -4.2% 6.85 US$20,550
2005-01-11 2005-01-07 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
500 -0.7%
7.00
US$3,500 		500 -0.7% 7.00 US$3,500
2004-01-09 2004-01-08 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
2,200 -3.0%
12.80
US$28,160 		2,200 -3.0% 12.80 US$28,160
2004-01-09 2004-01-08 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
500 -0.7%
12.87
US$6,435 		500 -0.7% 12.87 US$6,435
2004-01-09 2004-01-08 S Sale FRIEDMAN ERIC J

Chief Financial Officer

Officer
300 -0.4%
12.90
US$3,870 		300 -0.4% 12.90 US$3,870
Explore more

More insider trading research around Integrated Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America